Exploiting virus-like particles as innovative vaccines against emerging viral infections

Hotcherl Jeong, Baik Lin Seong

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Emerging viruses pose a major threat to humans and livestock with global public health and economic burdens. Vaccination remains an effective tool to reduce this threat, and yet, the conventional cell culture often fails to produce sufficient vaccine dose. As an alternative to cell-culture based vaccine, virus-like particles (VLPs) are considered as a highpriority vaccine strategy against emerging viruses. VLPs represent highly ordered repetitive structures via macromolecular assemblies of viral proteins. The particulate nature allows efficient uptake into antigen presenting cells stimulating both innate and adaptive immune responses towards enhanced vaccine efficacy. Increasing research activity and translation opportunity necessitate the advances in the design of VLPs and new bioprocessing modalities for efficient and cost-effective production. Herein, we describe major achievements and challenges in this endeavor, with respect to designing strategies to harnessing the immunogenic potential, production platforms, downstream processes, and some exemplary cases in developing VLP-based vaccines.

Original languageEnglish
Pages (from-to)220-230
Number of pages11
JournalJournal of Microbiology
Volume55
Issue number3
DOIs
Publication statusPublished - 2017 Mar 1

Fingerprint

Virus Diseases
Virus-Like Particle Vaccines
Virion
Vaccines
Cell Culture Techniques
Viruses
Livestock
Adaptive Immunity
Viral Proteins
Antigen-Presenting Cells
Innate Immunity
Vaccination
Public Health
Economics
Costs and Cost Analysis
Research

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Applied Microbiology and Biotechnology

Cite this

@article{61165f2dd1264790882f254e26cb1f5b,
title = "Exploiting virus-like particles as innovative vaccines against emerging viral infections",
abstract = "Emerging viruses pose a major threat to humans and livestock with global public health and economic burdens. Vaccination remains an effective tool to reduce this threat, and yet, the conventional cell culture often fails to produce sufficient vaccine dose. As an alternative to cell-culture based vaccine, virus-like particles (VLPs) are considered as a highpriority vaccine strategy against emerging viruses. VLPs represent highly ordered repetitive structures via macromolecular assemblies of viral proteins. The particulate nature allows efficient uptake into antigen presenting cells stimulating both innate and adaptive immune responses towards enhanced vaccine efficacy. Increasing research activity and translation opportunity necessitate the advances in the design of VLPs and new bioprocessing modalities for efficient and cost-effective production. Herein, we describe major achievements and challenges in this endeavor, with respect to designing strategies to harnessing the immunogenic potential, production platforms, downstream processes, and some exemplary cases in developing VLP-based vaccines.",
author = "Hotcherl Jeong and Seong, {Baik Lin}",
year = "2017",
month = "3",
day = "1",
doi = "10.1007/s12275-017-7058-3",
language = "English",
volume = "55",
pages = "220--230",
journal = "Journal of Microbiology",
issn = "1225-8873",
publisher = "Microbiological Society of Korea",
number = "3",

}

Exploiting virus-like particles as innovative vaccines against emerging viral infections. / Jeong, Hotcherl; Seong, Baik Lin.

In: Journal of Microbiology, Vol. 55, No. 3, 01.03.2017, p. 220-230.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Exploiting virus-like particles as innovative vaccines against emerging viral infections

AU - Jeong, Hotcherl

AU - Seong, Baik Lin

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Emerging viruses pose a major threat to humans and livestock with global public health and economic burdens. Vaccination remains an effective tool to reduce this threat, and yet, the conventional cell culture often fails to produce sufficient vaccine dose. As an alternative to cell-culture based vaccine, virus-like particles (VLPs) are considered as a highpriority vaccine strategy against emerging viruses. VLPs represent highly ordered repetitive structures via macromolecular assemblies of viral proteins. The particulate nature allows efficient uptake into antigen presenting cells stimulating both innate and adaptive immune responses towards enhanced vaccine efficacy. Increasing research activity and translation opportunity necessitate the advances in the design of VLPs and new bioprocessing modalities for efficient and cost-effective production. Herein, we describe major achievements and challenges in this endeavor, with respect to designing strategies to harnessing the immunogenic potential, production platforms, downstream processes, and some exemplary cases in developing VLP-based vaccines.

AB - Emerging viruses pose a major threat to humans and livestock with global public health and economic burdens. Vaccination remains an effective tool to reduce this threat, and yet, the conventional cell culture often fails to produce sufficient vaccine dose. As an alternative to cell-culture based vaccine, virus-like particles (VLPs) are considered as a highpriority vaccine strategy against emerging viruses. VLPs represent highly ordered repetitive structures via macromolecular assemblies of viral proteins. The particulate nature allows efficient uptake into antigen presenting cells stimulating both innate and adaptive immune responses towards enhanced vaccine efficacy. Increasing research activity and translation opportunity necessitate the advances in the design of VLPs and new bioprocessing modalities for efficient and cost-effective production. Herein, we describe major achievements and challenges in this endeavor, with respect to designing strategies to harnessing the immunogenic potential, production platforms, downstream processes, and some exemplary cases in developing VLP-based vaccines.

UR - http://www.scopus.com/inward/record.url?scp=85014020006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014020006&partnerID=8YFLogxK

U2 - 10.1007/s12275-017-7058-3

DO - 10.1007/s12275-017-7058-3

M3 - Review article

C2 - 28243941

AN - SCOPUS:85014020006

VL - 55

SP - 220

EP - 230

JO - Journal of Microbiology

JF - Journal of Microbiology

SN - 1225-8873

IS - 3

ER -